<DOC>
	<DOCNO>NCT00215878</DOCNO>
	<brief_summary>The aim study asses effect NMDA receptor full agonist D-serine use adjuvant treatment individual suffer chronic posttraumatic stress disorder ( PTSD ) . Dysfunction neurotransmission mediate NMDA receptor play cardinal role pathophysiology PTSD PTSD patient typically suffer cognitive dysfunction avoidance &amp; depressive symptomatology may mediate NMDA receptor function deficit . Thus , enhancement NMDA activity use D-serine may beneficial treatment PTSD . The study design involve two 6 week period participant randomly assign receive treatment D-serine ( ~2g /dy ) placebo . This design allow participant opportunity respond experimental treatment .</brief_summary>
	<brief_title>D-serine Posttraumatic Stress Disorder Treatment</brief_title>
	<detailed_description />
	<mesh_term>Disease</mesh_term>
	<mesh_term>Stress Disorders , Traumatic</mesh_term>
	<mesh_term>Stress Disorders , Post-Traumatic</mesh_term>
	<criteria>â€¢ Chronic PTSD ( DSMIV diagnosis ) Other psychiatric diagnosis Substance abuse Unstable medical condition</criteria>
	<gender>All</gender>
	<minimum_age>25 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>July 2012</verification_date>
</DOC>